Related Experiment Video
Updated: Dec 31, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Acute right heart failure: future perspective with the PERKAT RV pulsatile right ventricular support device
Markus W Ferrari1, P Christian Schulze2, Daniel Kretzschmar2
1Director of the Clinic Internal Medicine 1, Helios Dr. Horst Schmidt Clinic, Ludwig-Erhard-Strasse 100, Wiesbaden, Hessen, 65199, Germany.
Abstract:
Acute right heart failure is associated with impaired prognosis in cardiogenic shock. Since most pharmacological therapies are not evaluated for the failing right ventricle, or even contraindicated, there is a need for rapid minimal invasive circulatory right heart support. The PERKAT RV is such a device for acute therapy in congestive heart failure. It reduces the central venous pooling by pumping blood from the inferior vena cava into the pulmonary artery with flow rates of up to 4 litres/min. The device was evaluated in an animal model of acute pulmonary embolism after careful in vitro tests. PERKAT RV increased cardiac output by 59% in sheep suffering from acute right heart failure. We await the first human implantation in the near future. Based on the PERKAT concept, future devolvement will also focus on left heart support.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Regurgitation I: Introduction
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure II: Pathophysiology

